﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Pharmaceutical Sciences</JournalTitle>
      <Issn>1735-403X</Issn>
      <Volume>32</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2026</Year>
        <Month>07</Month>
        <DAY>31</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Development of 3D-QSAR Models to Predict Inhibition Activity of Selective Histone Deacetylase 1-3 Inhibitors</ArticleTitle>
    <FirstPage>441</FirstPage>
    <LastPage>450</LastPage>
    <ELocationID EIdType="doi">10.34172/ps.42810</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Narges</FirstName>
        <LastName>Cheshmazar</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-9998-8121</Identifier>
      </Author>
      <Author>
        <FirstName>Amirhossein</FirstName>
        <LastName>Nasri</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0006-9537-4890</Identifier>
      </Author>
      <Author>
        <FirstName>Siavoush</FirstName>
        <LastName>Dastmalchi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-9427-0770</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/ps.42810</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>06</Month>
        <Day>09</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>09</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Histone deacetylase inhibitors (HDACIs) have attracted researchers’ attention as anti-cancer agents. Designing novel HDAC inhibitors is important in drug discovery field of HDAC due to their high potency, less off-target effects, and good pharmacokinetic and pharmacodynamic profiles. 3D quantitative structure-activity relationship (3D‐QSAR) is a computational method used to design novel compounds considering 3D structure of molecules. Methods: In the current study, we have performed two successive QSAR analyses including a classification based for recognizing selective HDAC1-3 inhibitors from non-selective inhibitors and a 3D-QSAR to predict the potency of inhibitors. To this, initially a classification based QSAR was developed to filter selective HDAC1-3 inhibitors from other isoform-selective or pan inhibitors. Also, a receiver operating characteristics (ROC) analysis was performed for evaluation the goodness of classification model performance. Then, three different 3D-QSAR models were developed specifically for the filtered selective HDAC1-3 inhibitors to assess their selectivity and potency. Results: The generated models revealed that some common structural moieties have positive or negative effect towards the potency of the studied compounds against all three HDAC 1-3 isoforms. The results indicated that out of the identified important variables, a variable named DRY-TIP showing the optimum distance between ZBG and cap group. Furthermore, presence of two HBD groups in ZBD to form pseudoring with a zinc ion present in the active site of the enzyme are essential for exerting inhibitory activity. Using partial least square analysis, a 3D-QSAR model with 5 latent variables was generated with q2 values of internal and external validation equal to 0.62, 0.84, 0.83 and 0.72, 0.90, 0.82 for HDAC1,2,3, respectively. Conclusion: The result of the current study can be used to recognize selective HDAC1-3 inhibitors and predict their potencies with the aim of selective HDAC1-3 inhibitor design. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Histone deacetylase</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Selective HDAC1-3 inhibitor</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">GRIND</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">3D-QSAR</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Docking</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Classification</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>